Cargando…

Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysis

Effect modification occurs while the effect of the treatment is not homogeneous across the different strata of patient characteristics. When the effect of treatment may vary from individual to individual, precision medicine can be improved by identifying patient covariates to estimate the size and d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Schnitzer, Mireille E, Wang, Guanbo, Kennedy, Edward, Viiklepp, Piret, Vargas, Mario H, Sotgiu, Giovanni, Menzies, Dick, Benedetti, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961254/ https://www.ncbi.nlm.nih.gov/pubmed/34903098 http://dx.doi.org/10.1177/09622802211046383

Ejemplares similares

Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysis
por: Johara, Fatema Tuj, et al.
Publicado: (2021)

Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2016)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
por: Winters, Nicholas, et al.
Publicado: (2023)

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method
por: Mitnick, Carole D., et al.
Publicado: (2016)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
por: Ahuja, Shama D., et al.
Publicado: (2012)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
por: Günther, Gunar, et al.
Publicado: (2015)

Correction: Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
por: Ahuja, Shama D., et al.
Publicado: (2012)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022)

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Hatami, Hossein, et al.
Publicado: (2022)

Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity
por: Adjobimey, Menonli, et al.
Publicado: (2021)

Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients
por: Oehadian, Amaylia, et al.
Publicado: (2022)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
por: Harausz, Elizabeth P., et al.
Publicado: (2018)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Treatment of drug-resistant tuberculosis
por: Pinto, Lancelot, et al.
Publicado: (2011)

Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

High Rate of Hypothyroidism in Multidrug-Resistant Tuberculosis Patients Co-Infected with HIV in Mumbai, India
por: Andries, Aristomo, et al.
Publicado: (2013)

Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
por: Menzies, Dick, et al.
Publicado: (2009)

Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
por: Menzies, Dick, et al.
Publicado: (2009)

Multidrug-Resistant Mycobacterium tuberculosis, Southwestern Colombia
por: Ferro, Beatriz E., et al.
Publicado: (2011)

Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
por: Devaux, Isabelle, et al.
Publicado: (2009)

Reply to Chang and Yew
por: Sotgiu, Giovanni, et al.
Publicado: (2020)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2022)

Identifying gaps in the quality of latent tuberculosis infection care
por: Hannah, Alsdurf, et al.
Publicado: (2020)

Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial
por: Fox, Greg J, et al.
Publicado: (2020)

Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
por: Oga-Omenka, Charity, et al.
Publicado: (2020)

A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria
por: Oga-Omenka, Charity, et al.
Publicado: (2021)

Four months of rifampicin monotherapy for latent tuberculosis infection in children
por: Oh, Chi Eun, et al.
Publicado: (2021)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines
por: Feuth, T., et al.
Publicado: (2021)

Nomogram for individualized prediction of incident multidrug-resistant tuberculosis after completing pulmonary tuberculosis treatment
por: Cheng, Qinglin, et al.
Publicado: (2020)

Modification of biological surface activity of particles
por: Schnitzer, R. J.
Publicado: (1974)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

Recent developments in treatment of latent tuberculosis infection
por: Menzies, Dick, et al.
Publicado: (2011)

Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study
por: Ronald, Lisa A., et al.
Publicado: (2016)

A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2013)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_m1a0hja06epmtu0g0v7kb651d6